Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000874015-13-000070
Filing Date
2013-06-26
Accepted
2013-06-26 20:11:23
Documents
1
Period of Report
2013-06-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2246
  Complete submission text file 0000874015-13-000070.txt   3541
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
Castleman Breaux (Reporting) CIK: 0001335073 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19125 | Film No.: 13935724